📣 VC round data is live. Check it out!
- Public Comps
- DGL Group
DGL Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for DGL Group and similar public comparables like eXoZymes, Amoeba, BRAIN Biotech, Exel Composites and more.
DGL Group Overview
About DGL Group
DGL Group Ltd is an investment holding company. The company's segment includes Chemical Manufacturing, Logistics and Environmental Services. It generates maximum revenue from the Chemical Manufacturing segment. The Chemical Manufacturing segment produces its own range of speciality chemicals and undertakes formulation and contract manufacturing on behalf of third parties.
Founded
1984
HQ

Employees
280
Website
Sectors
Financials (LTM)
EV
$188M
Valuation Multiples
Start free trialDGL Group Financials
DGL Group reported last 12-month revenue of $315M and EBITDA of $34M.
In the same LTM period, DGL Group generated $34M in EBITDA and had net loss of ($16M).
Revenue (LTM)
DGL Group P&L
In the most recent fiscal year, DGL Group reported revenue of $315M and EBITDA of $34M.
DGL Group is unprofitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 11%, and net margin of (5%).
Financial data powered by Morningstar, Inc.
DGL Group Stock Performance
DGL Group has current market cap of $81M, and enterprise value of $188M.
Market Cap Evolution
DGL Group's stock price is $0.28.
DGL Group share price increased by 5.1% in the last 30 days, and decreased by 3.5% in the last year.
DGL Group has an EPS (earnings per share) of $-0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $188M | $81M | 0.9% | 5.1% | — | -3.5% | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDGL Group Valuation Multiples
DGL Group trades at 0.6x EV/Revenue multiple, and 5.5x EV/EBITDA.
EV / Revenue (LTM)
DGL Group Financial Valuation Multiples
As of May 9, 2026, DGL Group has market cap of $81M and EV of $188M.
DGL Group has a P/E ratio of (5.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DGL Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


DGL Group Margins & Growth Rates
In the most recent fiscal year, DGL Group reported gross margin of 41%, EBITDA margin of 11%, and net margin of (5%).
DGL Group Margins
DGL Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
DGL Group Operational KPIs
DGL Group's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
DGL Group Competitors
DGL Group competitors include eXoZymes, Amoeba, BRAIN Biotech, Exel Composites, I-Tech, American Vanguard, Northern Technologies, IBU-tec adv materials, Baikowski and Holland.
Most DGL Group public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | (8.5x) | — | |||
| — | 46.6x | (13.0x) | (15.4x) | |||
| 1.4x | 1.3x | (103.5x) | 161.9x | |||
| 0.9x | 0.9x | 13.2x | 10.2x | |||
| 4.1x | 3.9x | 14.1x | 13.2x | |||
| 0.6x | 0.6x | (25.4x) | 7.6x | |||
| 1.0x | 0.9x | 15.6x | — | |||
| 1.6x | 2.0x | 81.3x | 21.2x | |||
This data is available for Pro users. Sign up to see all DGL Group competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DGL Group
| When was DGL Group founded? | DGL Group was founded in 1984. |
| Where is DGL Group headquartered? | DGL Group is headquartered in Australia. |
| How many employees does DGL Group have? | As of today, DGL Group has over 280 employees. |
| Is DGL Group publicly listed? | Yes, DGL Group is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of DGL Group? | DGL Group trades under DGL ticker. |
| When did DGL Group go public? | DGL Group went public in 2021. |
| Who are competitors of DGL Group? | DGL Group main competitors include eXoZymes, Amoeba, BRAIN Biotech, Exel Composites, I-Tech, American Vanguard, Northern Technologies, IBU-tec adv materials, Baikowski, Holland. |
| What is the current market cap of DGL Group? | DGL Group's current market cap is $81M. |
| What is the current revenue of DGL Group? | DGL Group's last 12 months revenue is $315M. |
| What is the current EV/Revenue multiple of DGL Group? | Current revenue multiple of DGL Group is 0.6x. |
| Is DGL Group profitable? | Yes, DGL Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of DGL Group? | DGL Group's last 12 months EBITDA is $34M. |
| What is DGL Group's EBITDA margin? | DGL Group's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of DGL Group? | Current EBITDA multiple of DGL Group is 5.5x. |
| How many companies DGL Group has acquired to date? | DGL Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies DGL Group has invested to date? | DGL Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to DGL Group
Lists including DGL Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.